Modulating airway defenses against microbes

Current Opinion in Pulmonary Medicine

Volumn 8, Issue 3, 2002, Pages 154-165

  Reynolds, Herbert Y ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACILLUS ANTHRACIS; BACTERIAL COLONIZATION; BACTERIAL PNEUMONIA; BORDETELLA PERTUSSIS; CHLAMYDOPHILA PNEUMONIAE; HOST RESISTANCE; HUMAN; INFECTION RISK; PORPHYROMONAS GINGIVALIS; REVIEW; STREPTOCOCCUS PNEUMONIAE;

EID: 0036112309     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200205000-00002     Document Type: Review

References (100)

1. Defense mechanisms against infections
2. Host-pathogen interactions: The attributes of virulence
3. Fluoroquinolone-resistant Streptococcus pneumoniae associated with levofloxacin therapy
4. Influenza vaccination for healthy young adults
5. Rethinking recommendations for use of pneumococcal vaccines in adults
6. Vaccines and vaccination (advances in immunology review)
7. Advances in understanding pulmonary host defense mechanisms: Dendritic cell function and immunodulation
8. Integrated host defenses against infections
9. Respiratory tract fluids: Analysis of content and contemporary use in understanding lung diseases
10. Correlation between respiratory tract protein obtained from upper (nasal) and lower (bronchial lavage) sites
11. Human ciliary beat frequency in epithelium from intrathoracic and extra thoracic airways
12. The effect of aging on nasal mucociliary clearance, beat frequency, and ultrastructure of respiratory cilia
13. Altered immune status in the elderly
14. Aging of lymphocytes and lymphocytes in the aged
15. T-cell phenotypes of the normal nasal mucosa: Induction of Th2 cytokines and CCR3 expression by IL-4
16. Lung inflammation: Normal host defense or a complication of some diseases
17. Macrophages and polymorphonuclear neutrophils in lung defense and injury: State of the art
18. Macrophage engulfment of apoptotic neutrophils contributes to the resolution of acute pulmonary inflammation in vivo
19. Mechanisms for the inflammatory response in primate lungs: Demonstration and partial characterization of an alveolar macrophage-derived chemotactic factor with preferential activity for polymorphonuclear leukocytes
20. Alveolar macrophage derived chemotactic factor
21. Human alveolar macrophage derived chemotactic factor for neutrophils
22. Leukotriene B4 production from human alveolar macrophages: A potential mechanism for amplifying inflammation in the lung
23. The relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the human alveolar macrophage
24. Neutrophil chemotactic activity produced by normal and activated human lung cells
25. Recombinant interferon-gamma primes alveolar macrophages cultured in vitro for the release of leukotriene B4 in response to IgC stimulation
26. Cytokines in host defense again pneumonia
27. Synovial tissue macrophage as a source of the chemotactic cytokine IL-8
28. Secretion of neutrophil attractant/activation protein by lipopolysaccharide-stimulated lung macrophages determined by both enzyme-linked immunosorbent assay and n-terminal sequence analysis
29. Neutrophil attractant/activation protein-1 (NAP-1 [Interleukin-8]): Update
30. Macrophages cultured in vitro release leukotriene B4 and neutrophil attractant/activation protein (interleukin 8) sequentially in response to stimulation with lipopolysaccharide and zymosan
31. Acute lung injury: The role of cytokines in the elicitation of neutrophils
32. Human alveolar macrophages release a factor which inhibits phagocyte function
33. Isolation of an inhibitor of neutrophil function from bronchial lavage of normal volunteers
34. Partial characterization of a neutrophil inhibitor peptide harvested from human bronchial lavage: Homology to influenza A nucleoprotein
35. Effects of influenza A nucleoprotein on polymorphonuclear neutrophil function
36. Attenuation of interleukin 8-induced nasal inflammation by a inhibitor protein
37. Gut- and bronchus-associated lymphoid tissue
38. Human airway macrophages - A technique for their retrieval and a descriptive comparison with alveolar macrophages
39. Lung dendritic cells and host immunity to infection
40. Dendritic cells and the control of immunity
41. Dendritic cells: Specialized and regulated antigen processing machines
42. Cytokines: Role in respiratory illnesses and potential control with immunomodulatory therapy
43. Induction of CTL and nonpolarized Th cell responses by CD8α+ and CD8α- dendritic cells
44. Cytokines regulate the capacity of CD8α+ and CD8α- dendritic cells to prime Th1/Th2 cells in vivo
45. CDS-dendritic cell activation status plays an integral role in influencing Th2 response development
46. The source of early IFN-γ that plays a role in Th1 priming
47. Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2
48. Critical role of lipopolysaccharide-binding protein and CD14 in immune responses against gram-negative bacteria
49. Structure and function of human IgA Fc receptors (FcαR)
50. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities
51. Antigen-pulsed dendritic cells expressing macrophage-derived chemokine elicit Th2 responses and promote specific humoral immunity
52. The host-pathogen interaction: New themes from dendritic cell biology
53. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen
54. Migration and maturation of human colonic dendritic cells
55. Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells
56. Mechanism of suppression of cell-mediated immunity by measles virus
57. Natural measles causes prolonged suppression of interleukin-12 production
58. Dendritic cells recruitment and in vivo priming of CD8+ CTL induced by a single topical or transepithelial immunization via the buccal mucosa with measles virus nucleoprotein
59. Mature dendritic cells infiltrate the T cell-rich region of oral mucosa in chronic periodontitis: In situ, in vivo and in vitro studies
60. Chronic bronchitis and acute infectious exacerbations
61. Respiratory infections: Community-acquired pneumonia and newer microbes
62. Adherence of Bordetella pertussis to human respiratory epithelial cells
63. Comparison of values of antibody to Bordetella pertussis antigens in young German and American men
64. Pertussis in adults: Editorial
65. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents
66. Prevalence and incidence of adult pertussis in an urban population
67. Evaluation of pertussis in U.S. marine corps trainees
68. Bordetella pertussis and chronic cough in adults
69. Infections caused by Chlamydia pneumoniae strain TWAR
70. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis
71. Chlamydia pneumoniae infection in patients with cystic fibrosis
72. Detection of anti-Chlamydia pneumoniae IgE in children with reactive airway disease
73. Tracking the TWAR organism
74. Chronic infection in the aetiology of atherosclerosis: Focus on Chlamydia pneumoniae
75. Chlamydia pneumoniae-induced ciliostasis in ciliated bronchial epithelial cells
76. Predominant role of Toll-like receptor 2 versus 4 in Chlamydia pneumoniae-induced activation of dendritic cells
77. Chronic Chlamydia pneumoniae and asthma exacerbation in children
78. Trial of roxithromycin in subjects with asthma and serological evidence of infection with asthma and serological evidence of infection with Chlamydia pneumoniae
79. Is Chlamydia pneumoniae important in Asthma? The first controlled trial of therapy leaves the question unanswered
80. Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura
81. Immunoglobulin G and its function in the human respiratory tract
82. Surfactant protein A. Regulation of innate and adaptive immune responses in lung inflammation
83. A pneumococcal protein that elicits interleukin-8 from pulmonary epithelial cells
84. Practice guidelines for the management of community-acquired pneumonia in adults
85. Pneumococcal vaccination: Current and future issues
86. Anthrax as a biological weapon-medical and public health management
87. Be alert to anthrax clues, doctors are told
88. Bioterrorism: An update for clinicians, pharmacists and emergency management planners
89. Recognition and management of anthrax - An update
90. Post exposure prophylaxis against experimental inhalation anthrax
91. The Sverdlovsk anthrax outbreak in 1979
92. Dendritic cells in cancer immunotherapy
93. Dendritic cells as vectors for therapy
94. CD4+ T cell-independent vaccination against Pneumocystis carinni in mice
95. Targeting IgE in treatment of asthma
96. Could the risk of asthma and atopy be reduced by a vaccine that induces a strong T-helper Type 1 response?
97. Could asthma be worsened by stimulating the T-helper Type 1 immune response?
98. Is asthma really due to a polarized T cell response toward a helper T cell Type 2 phenotype?
99. Sampling local respiratory tract sites for inflammation